Mitochondrial control of protein translation in Fragile X

脆性 X 蛋白翻译的线粒体控制

基本信息

  • 批准号:
    10379427
  • 负责人:
  • 金额:
    $ 58.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Abstract Loss of function of the gene (Fmr1) encoding Fragile X mental retardation protein (FMRP) results in unregulated mRNA translation and aberrant synaptic morphology. We find that mitochondria in neurons of the Fmr1-/y mouse have an inner membrane leak that undermines ATP synthesis and contributes to a replicative phenotype that is a hallmark of immature, dividing cells. Previous work in cardiomyocytes showed that developmental maturation is dependent on closure of a mitochondrial membrane leak. We now find that mild depletion of ATP synthase c-subunit to reduce the leak or inhibition of the c-subunit leak with ATP synthase interacting agents decreases mRNA translation in Fmr1-/y mouse neurons and human fibroblasts. Leak inhibition alters metabolism in favor of oxidative phosphorylation. The developmental metabolic switch may be dependent on stimulus-induced phosphorylation of translation elongation factor 2 (EF2), an event which is lacking in Fmr1-/y synapses. Our data support a role for mitochondrial inner membrane efficiency in determining the rate and type of protein translation. We suggest that increased oxidative phosphorylation efficiency induced by closure of the ATP synthase c-subunit leak channel produces mitochondrial ATP in response to synaptic stimulation to phosphorylate EF2 and change the synaptic proteome. Thus, we will determine if pharmacological reagents that decrease inner membrane leak will do so in recordings of mitochondria isolated from Fmr1-/y synapses and if these reagents reverse the change in ATP synthase stoichiometry that causes increased c-subunit expression and inner mitochondrial membrane leak in the Fmr1-/Y mouse (Aim#1). We will assess synapse formation and plasticity (Aim #2) and behavior (Aim #3) following closure of the leak in cultured neurons or in vivo using dexpramipexole (Dex) and CoQ10. Dex is a cell death modulator that binds to the OSCP/b subunit of ATP synthase and closes the ATP synthase leak without affecting the immune system. It readily crosses the blood brain barrier, enhances ATP production in neurons and was recently studied in patients. Thus, both Dex and CoQ10 have excellent translational potential if successful. Finally, we will cross breed Fmr1-/Y mice with mice harboring a genetically modified ATP synthase c-subunit ring to determine if genetic reduction of the inner membrane leak rescues the FX synaptic phenotype. We suggest that FMRP regulates a stimulus-dependent change in mitochondrial metabolism required for normal synaptic development and plasticity.
摘要 编码脆性X智力低下蛋白(FMRP)的基因(Fmr 1)功能丧失导致 不受控制的mRNA翻译和异常的突触形态。我们发现, Fmr 1-/y小鼠的神经元具有破坏ATP合成的内膜渗漏, 有助于复制表型,这是不成熟的分裂细胞的标志。以前的工作 在心肌细胞中的研究表明,发育成熟依赖于关闭一个 线粒体膜渗漏。我们现在发现ATP合酶c亚基的轻度缺失, 减少渗漏或用ATP合酶相互作用剂抑制c-亚基渗漏 Fmr 1-/y小鼠神经元和人成纤维细胞中的mRNA翻译。泄漏抑制改变 代谢有利于氧化磷酸化。发育代谢开关可能是 依赖于刺激诱导的翻译延伸因子2(EF 2)磷酸化, 这是在Fmr 1-/y突触中缺乏的。我们的数据支持线粒体内膜 确定蛋白质翻译的速率和类型的效率。我们建议增加 ATP合成酶c亚基泄漏关闭诱导的氧化磷酸化效率 通道响应突触刺激产生线粒体ATP以磷酸化EF 2 改变突触蛋白质组。因此,我们将确定, 减少内膜泄漏将在从Fmr 1-/y分离的线粒体记录中起到这样的作用 突触,如果这些试剂逆转ATP合酶化学计量的变化, 在Fmr 1-/Y小鼠中增加的c-亚基表达和线粒体内膜渗漏 (Aim#1)。我们将评估突触形成和可塑性(目标#2)和行为(目标#3), 使用右旋普拉克索(Dex)和辅酶Q10在培养的神经元中或在体内封闭渗漏。德克斯是 一种与ATP合酶的OSCP/B亚单位结合并关闭ATP的细胞死亡调节剂 合成酶泄漏而不影响免疫系统。它很容易穿过血脑屏障, 增强神经元中ATP的产生,最近在患者中进行了研究。因此,Dex和 辅酶Q10如果成功,具有很好的翻译潜力。最后,我们将杂交Fmr 1-/Y 小鼠与携带遗传修饰的ATP合酶c亚基环的小鼠,以确定 内膜渗漏的遗传减少挽救了FX突触表型。我们建议 FMRP调节线粒体代谢的刺激依赖性变化, 正常的突触发育和可塑性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kambiz Nassirpour Alavian其他文献

Kambiz Nassirpour Alavian的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kambiz Nassirpour Alavian', 18)}}的其他基金

Mitochondrial control of protein translation in Fragile X
脆性 X 蛋白翻译的线粒体控制
  • 批准号:
    10599936
  • 财政年份:
    2019
  • 资助金额:
    $ 58.19万
  • 项目类别:
Role of Bcl-xL in neuronal mitochondrial calcium dynamics
Bcl-xL 在神经元线粒体钙动力学中的作用
  • 批准号:
    8604982
  • 财政年份:
    2013
  • 资助金额:
    $ 58.19万
  • 项目类别:
Role of Bcl-xL in neuronal mitochondrial calcium dynamics
Bcl-xL 在神经元线粒体钙动力学中的作用
  • 批准号:
    8688373
  • 财政年份:
    2013
  • 资助金额:
    $ 58.19万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 58.19万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了